Slideshow
Author(s):
Highlights include how cost-effective insulin reduces hospital visits; prevalence of restrictive lung disease in T2DM patients; and the wonders of self-monitoring for cost of care.
Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology
HHS Targets 15 Drugs for Medicare Part D Negotiations, Including Semaglutide
Diabetes Dialogue: The Evolving Role of Registered Dietitian Nutritionists in Obesity
GLP-1 RAs Provide Greater Hepatic Benefit Than SGLT2is For MASLD, Type 2 Diabetes
FMT Shows Promise for Type 1 Diabetes, Gastroenteropathy Treatment in Pilot Trial